open access

Online first
Expert opinion
Published online: 2021-09-21
Get Citation

Transcatheter mitral valve repair and replacement. Expert consensus statement of the Polish Cardiac Society and the Polish Society of Cardiothoracic Surgeons

Wojciech Wojakowski1, Zbigniew Chmielak2, Kazimierz Widenka3, Jerzy Pręgowski2, Bartłomiej Perek4, Andrzej Gackowski5, Krzysztof Bartuś6, Piotr Szymański7, Marek A Deja8, Zbigniew Kalarus9, Piotr Suwalski10, Jarosław Trębacz11, Piotr Kołsut12, Piotr Ścisło13, Krzysztof Wróbel14, Grzegorz Smolka1, Witold Gerber15, Dariusz Dudek1617, Tomasz Hirnle18, Marek Grygier19, Stanisław Bartuś20, Adam Witkowski2, Mariusz Kuśmierczyk12
DOI: 10.33963/KP.a2021.0116
·
Pubmed: 34599502
Affiliations
  1. Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
  2. Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warszawa, Poland
  3. Clinical Department of Cardiac Surgery, District Hospital no. 2, University of Rzeszow, Rzeszów, Poland
  4. Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznań, Poland
  5. Noninvasive Cardiovascular Laboratory, John Paul II Hospital, Kraków, Poland; Jagiellonian University Medical College, Institute of Cardiology, Department of Coronary Artery Disease and Heart Failure, John Paul II Hospital, Kraków, Poland
  6. Department of Cardiovascular Surgery and Transplantation, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland
  7. Clinical Cardiology Center, Central Clinical Hospital of the Ministry of the Interior in Warsaw and Center of Postgraduate Medical Education, Warszawa, Poland
  8. Department of Cardiac Surgery, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  9. Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland
  10. Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, Warszawa, Poland
  11. Institute of Cardiology, Jagiellonian University, Kraków, Poland
  12. Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, Warszawa, Poland
  13. 1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland 14Medicover Hospital, Warszawa, Poland
  14. Medicover Hospital, Warszawa, Poland
  15. Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland
  16. Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
  17. Maria Cecilia Hospital, GVM Care and Research, Contignola (RA), Ravenna, Italy
  18. Department of Cardiosurgery, University Hospital, Białystok, Poland
  19. 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
  20. 2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland

open access

Online first
Expert opinion and position paper
Published online: 2021-09-21

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

edge-to-edge repair, mitral valve regurgitation, transcatheter valve repair, transcatheter valve replacement

About this article
Title

Transcatheter mitral valve repair and replacement. Expert consensus statement of the Polish Cardiac Society and the Polish Society of Cardiothoracic Surgeons

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Expert opinion

Published online

2021-09-21

DOI

10.33963/KP.a2021.0116

Pubmed

34599502

Keywords

edge-to-edge repair
mitral valve regurgitation
transcatheter valve repair
transcatheter valve replacement

Authors

Wojciech Wojakowski
Zbigniew Chmielak
Kazimierz Widenka
Jerzy Pręgowski
Bartłomiej Perek
Andrzej Gackowski
Krzysztof Bartuś
Piotr Szymański
Marek A Deja
Zbigniew Kalarus
Piotr Suwalski
Jarosław Trębacz
Piotr Kołsut
Piotr Ścisło
Krzysztof Wróbel
Grzegorz Smolka
Witold Gerber
Dariusz Dudek
Tomasz Hirnle
Marek Grygier
Stanisław Bartuś
Adam Witkowski
Mariusz Kuśmierczyk

References (39)
  1. Petrus AHJ, Dekkers OM, Tops LF, et al. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J. 2019; 40(27): 2206–2214.
  2. Orban M, Rommel KP, Ho EC, et al. Transcatheter edge-to-edge tricuspid repair for severe tricuspid regurgitation reduces hospitalizations for heart failure. JACC Heart Fail. 2020; 8(4): 265–276.
  3. Mehr M, Karam N, Taramasso M, et al. TriValve and TRAMI Investigators. Combined tricuspid and mitral versus isolated mitral valve repair for severe MR and TR: an analysis from the TriValve and TRAMI registries. JACC Cardiovasc Interv. 2020; 13(5): 543–550.
  4. Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019; 8(17): e013332.
  5. Baumgartner H, Falk V, Bax JJ, et al. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739–2791.
  6. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005; 46(11): 2134–2140.
  7. Feldman T, Foster E, Glower DD, et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364(15): 1395–1406.
  8. Feldman T, Kar S, Elmariah S, et al. EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015; 66(25): 2844–2854.
  9. Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018; 379(24): 2297–2306.
  10. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018; 379(24): 2307–2318.
  11. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging. 2019; 20(6): 620–624.
  12. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013; 62(12): 1052–1061.
  13. Kalbacher D, Schäfer U, V Bardeleben RS, et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. Int J Cardiol. 2019; 277: 35–41.
  14. Attizzani GF, Ohno Y, Capodanno D, et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc Interv. 2015; 8(1 Pt A): 74–82.
  15. Grasso C, Capodanno D, Rubbio AP, et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol. 2013; 111(10): 1482–1487.
  16. Takagi H, Ando T, Umemoto T, et al. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. Int J Cardiol. 2017; 228: 289–294.
  17. Besler C, Noack T, von Roeder M, et al. Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series. EuroIntervention. 2020; 16(10): 824–832.
  18. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e35–e71.
  19. Gössl M, Sorajja P. MitraClip patient selection: inclusion and exclusion criteria for optimal outcomes. Ann Cardiothorac Surg. 2018; 7(6): 771–775.
  20. Yeo KK, Yap J, Tan JW, et al. Venous access closure using the double-proglide preclose technique after MitraClip implantation: long-term clinical and duplex ultrasound outcomes. J Invasive Cardiol. 2016; 28(2): 40–43.
  21. MitraClip provides valve repair without surgery. Harv Heart Lett. 2014; 24(6): 8.
  22. Schueler R, Öztürk C, Wedekind JA, et al. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. JACC Cardiovasc Interv. 2015; 8(3): 450–459.
  23. Morikawa T, Miyasaka M, Flint N, et al. Right-to-Left shunt through iatrogenic atrial septal defect after MitraClip procedure. JACC Cardiovasc Interv. 2020; 13(13): 1544–1553.
  24. Kadado AJ, Islam A. Iatrogenic atrial septal defect following the MitraClip procedure: A state-of-the-art review. Catheter Cardiovasc Interv. 2021; 97(7): E1043–E1052.
  25. Lurz P, Unterhuber M, Rommel KP, et al. Closure of iatrogenic atrial septal defect after transcatheter mitral valve repair: the randomized MITHRAS trial. Circulation. 2021; 143(3): 292–294.
  26. von Bardeleben RS, Hobohm L, Kreidel F, et al. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants. EuroIntervention. 2019; 14(17): 1725–1732.
  27. Isogai T, Saad AM, Shekhar S, et al. Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system. Catheter Cardiovasc Interv. 2021; 97(2): 335–341.
  28. Thomas F, Rader F, Siegel RJ. The use of MitraClip for symptomatic patients with hypertrophic obstructive cardiomyopathy. Cardiology. 2017; 137(1): 58–61.
  29. Płońska-Gościniak E, Suwalski P, Bartuś S, et al. Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol. 2020; 78(5): 498–507.
  30. Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012; 14(8): 931–938.
  31. Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail. 2019; 7(11): 945–955.
  32. Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2019; 40(5): 466–472.
  33. Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018; 54(3): 460–466.
  34. Gammie JS, Bartus K, Gackowski A, et al. Beating-Heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol. 2018; 71(1): 25–36.
  35. Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016; 134(3): 189–197.
  36. Kiefer P, Meier S, Noack T, et al. Good 5-year durability of transapical beating heart off-pump mitral valve repair with neochordae. Ann Thorac Surg. 2018; 106(2): 440–445.
  37. Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019; 8(17): e013332.
  38. Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients JACC. J Am Coll Cardiol. 2019; 73(11): 1250–1260.
  39. Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021 [Epub ahead of print]: ehab395.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl